Home › NDC Lookup › RxCUI directory › RxCUI 2105817

Gilteritinib 40 MG Oral Tablet [Xospata] — RxCUI 2105817

RxNorm drug concept · Semantic branded drug
RxCUI 2105817 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2105817
Official nameGilteritinib 40 MG Oral Tablet [Xospata]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXospata (as gilteritinib fumarate 44.2 MG) 40 MG Oral Tablet; XOSPATA 40 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)302 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gilteritinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Xospata targets a protein called FLT3 that is mutated in your leukemia cells — think of it as a stuck accelerator driving the cancer cells to multiply out of control. Gilteritinib...
  • What exactly is Xospata treating in my body?
  • You can take Xospata with or without food — that's one less thing to worry about. A high-fat meal does slightly delay how quickly the drug peaks in your bloodstream, but it doesn't...
  • Can I take Xospata with food, or does it matter?
📖 Read our full Gilteritinib guide →

🕸️ Concept Web — How Gilteritinib 40 MG Oral Tablet [Xospata] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gilteritinib 40 MG Oral Tablet [Xospata] RxCUI 2105817

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gilteritinib 2105806
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xospata 2105812
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gilteritinib Oral Tablet 2105810
    • Gilteritinib Oral Product 2105808
    • Gilteritinib Pill 2105809
    • Gilteritinib Oral Tablet [Xospata] 2105814
    • Xospata Oral Product 2105815
    • Xospata Pill 2105816
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gilteritinib 40 MG Oral Tablet SCD · 2105811
  • Gilteritinib 40 MG SCDC · 2105807
  • Gilteritinib Oral Tablet SCDF · 2105810
  • Gilteritinib Oral Product SCDG · 2105808
  • Gilteritinib Pill SCDG · 2105809

Brand-Name Concepts

  • Gilteritinib 40 MG [Xospata] SBDC · 2105813
  • Gilteritinib Oral Tablet [Xospata] SBDF · 2105814
  • Xospata Oral Product SBDG · 2105815
  • Xospata Pill SBDG · 2105816
  • Xospata BN · 2105812

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2105817 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00469-1425-21 1 BOTTLE in 1 CARTON (0469-1425-21) / 21 TABLET in 1 BOTTLE Xospata Astellas Pharma US, Inc. 2022-04-30
00469-1425-90 1 BOTTLE in 1 CARTON (0469-1425-90) / 90 TABLET in 1 BOTTLE Xospata Astellas Pharma US, Inc. 2018-11-29
Observed labelers: Astellas Pharma US, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.